Aripiprazole Monotherapy and Adjunctive Therapy for the Treatment of Psychosis and Mood Instability
Rated 4.7 out of 5.0 based on 7698 reviews
South Carolina Information
Pharmacotherapeutics Credits: 2.5
Related to prescribing controlled substances: 0
Course Summary
Aripiprazole is an atypical antipsychotic that is indicated for an array of psychiatric disease states. Being commonly known as a dopamine system stabilizer (DSS), aripiprazole is a first-line treatment option for adults diagnosed with schizophrenia, Bipolar I disorder, and major depressive disorder (MDD). Additionally, it may be utilized in children greater than six years of age with irritability associated with autism or tics secondary to Tourette's syndrome. Aripiprazole is unique among atypical antipsychotics due to the characteristics discussed below. Evidence exists in the literature to suggest that aripiprazole has potential neuroprotective effects.
Course Format
Homestudy
Course Syllabus
-
Introduction
-
Pharmacological Profile
-
Mechanism of Action, Labeled and Off-label Use
-
Dosing
-
Long-Acting Injectable
-
US Boxed Warning, Contraindications, and Adverse Effects
-
Labeled Warnings and Precautions
-
Aripiprazole Treatment of Psychotic and Nonpsychotic Disorders
-
Schizophrenia
-
Bipolar I Disorder
-
Major Depressive Disorder
-
Autistic Disorder
-
Tourette Syndrome
-
Other Uses for Aripiprazole
-
Aripiprazole and Suicidal Ideation
-
Case Study: Aripiprazole and Dementia
-
Summary